Portfolio concentration
As of April 30, 2026 · N-PORT
Holdings
339
Top-10 weight
50.67%
Effective holdings
?
The number of equal-weight positions that would produce this portfolio's concentration (1 ÷ Herfindahl index). A 500-stock fund dominated by a few mega-caps might have only ~100 effective holdings.
25
Crowding
?
The value-weighted average number of funds that also own this fund's positions. High = consensus/crowded picks; low = holdings few other funds own.
1394.3
Holdings
As of April 30, 2026 · N-PORT| # | Security | Ticker | Shares | Value | % of fund |
|---|---|---|---|---|---|
| 1 | LILLY ELI and CO | — | 370,443 | $346.22M | 12.13% |
| 2 | JOHNSON&JOHNSON | — | 1,110,650 | $255.28M | 8.94% |
| 3 | ABBVIE INC | — | 814,750 | $172.17M | 6.03% |
| 4 | UNITEDHEALTH GRP | — | 417,583 | $154.71M | 5.42% |
| 5 | MERCK & CO | — | 1,144,186 | $124.92M | 4.38% |
| 6 | AMGEN INC | — | 248,232 | $85.95M | 3.01% |
| 7 | THERMO FISHER SCIENTIFIC INC | — | 173,204 | $82.96M | 2.91% |
| 8 | GILEAD SCIENCES INC | — | 571,936 | $74.83M | 2.62% |
| 9 | INTUITIVE SURGICAL INC | — | 163,426 | $74.79M | 2.62% |
| 10 | ABBOTT LABS | — | 801,594 | $72.78M | 2.55% |
| 11 | PFIZER INC | — | 2,621,047 | $69.98M | 2.45% |
| 12 | BRISTOL-MYERS SQUIBB CO | — | 938,456 | $56.86M | 1.99% |
| 13 | DANAHER CORP | — | 293,052 | $52.44M | 1.84% |
| 14 | STRYKER CORP | — | 158,669 | $50.00M | 1.75% |
| 15 | VERTEX PHARMACEUTICALS INC | — | 116,958 | $49.99M | 1.75% |
| 16 | CVS HEALTH CORP | — | 585,200 | $48.74M | 1.71% |
| 17 | MEDTRONIC PLC | — | 590,998 | $47.85M | 1.68% |
| 18 | MCKESSON CORP | — | 56,896 | $46.38M | 1.62% |
| 19 | BOSTON SCIENTIFIC CORP | — | 683,394 | $39.37M | 1.38% |
| 20 | ELEVANCE HEALTH INC | — | 102,444 | $38.56M | 1.35% |
| 21 | THE CIGNA GROUP | — | 123,144 | $35.78M | 1.25% |
| 22 | REGENERON PHARMACEUTICALS INC | — | 47,616 | $33.67M | 1.18% |
| 23 | HCA HEALTHCARE INC | — | 73,639 | $31.99M | 1.12% |
| 24 | CENCORA INC | — | 84,961 | $26.17M | 0.92% |
| 25 | ZOETIS INC CL A | — | 203,147 | $23.36M | 0.82% |
| 26 | EDWARDS LIFESCIENCES CORP | — | 267,514 | $22.34M | 0.78% |
| 27 | CARDINAL HEALTH INC | — | 109,528 | $21.13M | 0.74% |
| 28 | IDEXX LABS INC | — | 36,805 | $20.64M | 0.72% |
| 29 | BECTON DICKINSON and CO | — | 131,388 | $19.58M | 0.69% |
| 30 | ALNYLAM PHARMACEUTICALS INC | — | 60,901 | $18.85M | 0.66% |
| 31 | AGILENT TECHNOLOGIES INC | — | 130,688 | $15.10M | 0.53% |
| 32 | RESMED INC | — | 67,289 | $14.39M | 0.50% |
| 33 | WATERS CORP | — | 45,335 | $14.02M | 0.49% |
| 34 | INSMED INC | — | 98,313 | $13.40M | 0.47% |
| 35 | HUMANA INC | — | 55,439 | $13.11M | 0.46% |
| 36 | BIOGEN INC | — | 67,622 | $12.80M | 0.45% |
| 37 | GE HEALTHCARE TECHNOLOGIES INC WI | — | 209,991 | $12.78M | 0.45% |
| 38 | NATERA INC | — | 60,581 | $12.49M | 0.44% |
| 39 | IQVIA HOLDINGS INC | — | 78,509 | $12.43M | 0.44% |
| 40 | CENTENE CORP | — | 226,652 | $12.17M | 0.43% |
| 41 | METTLER-TOLEDO INTL INC | — | 9,423 | $12.03M | 0.42% |
| 42 | VEEVA SYSTEMS-A | — | 71,993 | $11.23M | 0.39% |
| 43 | UNITED THERAPEUTICS CORP DEL | — | 18,852 | $10.77M | 0.38% |
| 44 | REVOLUTION MEDICINES INC | — | 74,541 | $10.74M | 0.38% |
| 45 | DEXCOM INC | — | 179,798 | $10.71M | 0.38% |
| 46 | QUEST DIAGNOSTICS INC | — | 51,278 | $9.96M | 0.35% |
| 47 | WEST PHARMACEUTICAL SVCS INC | — | 33,185 | $9.88M | 0.35% |
| 48 | STERIS PLC | — | 45,282 | $9.82M | 0.34% |
| 49 | LABCORP HOLDINGS INC | — | 38,214 | $9.81M | 0.34% |
| 50 | ROYALTY PHARMA PLC | — | 186,793 | $9.36M | 0.33% |
1 / 7
Next ›
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.